Boehringer Ingelheim Vetmedica GmbH

Company Premium

Boehringer Ingelheim Animal Health Business Unit

Boehringer Ingelheim is the second largest animal health business in the world, with net sales of 4 billion euros in 2019 and presence in more than 150 markets.

As the lives of animals and humans are intertwined, across the globe, our 10,000 employees are dedicated to enhancing the well-being of both – through science and innovation, as well as with their commitment and passion.

Respect for animals, people and the environment is at the heart of what we do. We develop medicines, services and innovative digital technologies to protect animals from disease and pain. We support our customers in taking care of the health of their animals and protect our communities against life- and society- threatening diseases.

For more information visit: www.boehringer-ingelheim.com/animal-health/overview

 

Transmission routes, control and prevention of PRRS

30-Jan-2015
PRRS virus infection can be considered common in areas of high pig density and, in such cases, the idea that biosecurity and can do little is widespread. However, proper biosecurity measures must be implemented in order to prevent the introduction of new strains.

Welcome to 333

Connect, share, and interact with the largest community of professionals in the swine industry.

Celebrating 153729Users on 333!

Sign upAlready a member?
Recommended accounts
DAVI  LIOU

DAVI LIOU

Other - China
Zhou  Lydia

Zhou Lydia

Other - China
Kemin

Kemin

Company - Belgium
Boehringer Ingelheim Vetmedica GmbH
Company - Germany
pig333

pig333

Company - Spain